This is market research for a national mandatory requirements contract to supply Roflumilast Tablets to the VA, DoD, IHS, BOP, and FHCC, with all strengths and sizes awarded in aggregate for a base year and option years. Pricing is expected to be lower than FSS/Open Market prices based on committed volume. The government is gathering capability information on minimum requirements, including possession of a unique 11-digit NDC/labeler code, provision of a manufacturer commitment letter if not the manufacturer, and having chargeback agreements in place with VA/DoD pharmaceutical prime vendors. Respondents are asked for business size under NAICS 325412, small business manufacturing percentage, Trade Agreements Act product status, and product/bottle suitability. No specific budget amounts or timelines are provided in this notice.